@prefix biolink: . @prefix infores: . @prefix np: . @prefix npx: . @prefix orcid: . @prefix pav: . @prefix prov: . @prefix rdf: . @prefix rdfs: . @prefix sub: . @prefix this: . @prefix xsd: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { a biolink:ChemicalEntity; rdfs:label "Clonazepam"; biolink:category biolink:ChemicalEntity . a biolink:DiseaseOrPhenotypicFeature; rdfs:label "petit mal variant"; biolink:category biolink:DiseaseOrPhenotypicFeature . sub:_1 rdf:object ; rdf:predicate biolink:treats; rdf:subject ; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . } sub:provenance { sub:assertion prov:generatedAtTime "2022-10-28T11:22:45.539251"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0003-4727-9435; prov:wasQuotedFrom "Clonazepam is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures." . biolink: pav:version "2.3.0" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCTQs+mANCSHWhIW/YPio468UdGNHsPvADpjfaW8um/v2L4AoDIANginfoU65VNbPT5D0ADt1y0uFNne3VEMr9Y+I2HFaz6IKj+LdYMJk6VUf5WJoImRHIX6BZQwcUc22CbTBFYxvqvp3UmmHrCrhLIZjDSyutExK3tOTRoMDjGowIDAQAB"; npx:hasSignature "Lj8QpW0gSDODC0lKdF/+hpD4TI5jtO3Ft6uGHLZPZHBruazMFXRnxVccvVXhXWoI5qNK8s5Ee9Gtf8/TMHKbH4Xw4M04nBaNVVcTc1MBUhzCLvJCzf6KiPiZlS4WqsajQMc0lAD3RKYOZrj9I5nHVqKGMDkoeiDoPem1fHOPAXA="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2022-10-28T11:22:45.539251"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0003-4727-9435 . }